124 related articles for article (PubMed ID: 34231252)
1. Exploiting HIV-1 tropism to target CD4
Freen-van Heeren JJ
Immunol Cell Biol; 2021 Aug; 99(7):677-679. PubMed ID: 34231252
[No Abstract] [Full Text] [Related]
2. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X
Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597
[TBL] [Abstract][Full Text] [Related]
3. Finding host targets for HIV therapy.
Tsui CK; Gupta A; Bassik MC
Nat Genet; 2017 Jan; 49(2):175-176. PubMed ID: 28138150
[TBL] [Abstract][Full Text] [Related]
4. Picking the Survivor! CRISPR Reveals HIV Dependency Factors.
Schott K; König R
Trends Microbiol; 2017 Apr; 25(4):243-245. PubMed ID: 28233621
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9.
Li C; Guan X; Du T; Jin W; Wu B; Liu Y; Wang P; Hu B; Griffin GE; Shattock RJ; Hu Q
J Gen Virol; 2015 Aug; 96(8):2381-2393. PubMed ID: 25854553
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.
Xu L; Wang J; Liu Y; Xie L; Su B; Mou D; Wang L; Liu T; Wang X; Zhang B; Zhao L; Hu L; Ning H; Zhang Y; Deng K; Liu L; Lu X; Zhang T; Xu J; Li C; Wu H; Deng H; Chen H
N Engl J Med; 2019 Sep; 381(13):1240-1247. PubMed ID: 31509667
[TBL] [Abstract][Full Text] [Related]
7. Comments on the CRISPR Gene-edited babies' case.
Cong Y
Indian J Med Ethics; 2019; 4 (NS)(4):297-300. PubMed ID: 31791938
[TBL] [Abstract][Full Text] [Related]
8. HIV: CRISPR screen identifies novel therapeutic targets.
Crunkhorn S
Nat Rev Drug Discov; 2017 Feb; 16(2):88. PubMed ID: 28148946
[No Abstract] [Full Text] [Related]
9. Putting the spotlight on: CRISPR.
Lake F
Biotechniques; 2019 Oct; 67(4):150-152. PubMed ID: 31526035
[TBL] [Abstract][Full Text] [Related]
10. HEK293T Cells Are Heterozygous for CCR5 Delta 32 Mutation.
Qi C; Jia X; Lu L; Ma P; Wei M
PLoS One; 2016; 11(4):e0152975. PubMed ID: 27042825
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells.
Pfaff JM; Wilen CB; Harrison JE; Demarest JF; Lee B; Doms RW; Tilton JC
J Virol; 2010 Jul; 84(13):6505-14. PubMed ID: 20410277
[TBL] [Abstract][Full Text] [Related]
12. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.
van Rij RP; Blaak H; Visser JA; Brouwer M; Rientsma R; Broersen S; de Roda Husman AM; Schuitemaker H
J Clin Invest; 2000 Oct; 106(8):1039-52. PubMed ID: 11032864
[TBL] [Abstract][Full Text] [Related]
13. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.
Park RJ; Wang T; Koundakjian D; Hultquist JF; Lamothe-Molina P; Monel B; Schumann K; Yu H; Krupzcak KM; Garcia-Beltran W; Piechocka-Trocha A; Krogan NJ; Marson A; Sabatini DM; Lander ES; Hacohen N; Walker BD
Nat Genet; 2017 Feb; 49(2):193-203. PubMed ID: 27992415
[TBL] [Abstract][Full Text] [Related]
14. Starting the conversation: CRISPR's role in India.
Udwadia F; Singh S
Indian J Med Ethics; 2019; 4 (NS)(4):300-303. PubMed ID: 31213419
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal analysis of subtype C envelope tropism for memory CD4
Gartner MJ; Gorry PR; Tumpach C; Zhou J; Dantanarayana A; Chang JJ; Angelovich TA; Ellenberg P; Laumaea AE; Nonyane M; Moore PL; Lewin SR; Churchill MJ; Flynn JK; Roche M
Retrovirology; 2020 Aug; 17(1):24. PubMed ID: 32762760
[TBL] [Abstract][Full Text] [Related]
16. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.
Kato K; Sato H; Takebe Y
J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300
[TBL] [Abstract][Full Text] [Related]
17. A CCR5
Terahara K; Iwabuchi R; Hosokawa M; Nishikawa Y; Takeyama H; Takahashi Y; Tsunetsugu-Yokota Y
BMC Res Notes; 2019 Apr; 12(1):242. PubMed ID: 31036079
[TBL] [Abstract][Full Text] [Related]
18. Human Genome-Edited Babies: First Responder with Concerns Regarding Possible Neurological Deficits!
Baig AM
ACS Chem Neurosci; 2019 Jan; 10(1):39-41. PubMed ID: 30556694
[TBL] [Abstract][Full Text] [Related]
19. Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism.
Zhang Y; de Lara C; Worth A; Hegedus A; Laamanen K; Beverley P; Macallan D
PLoS Pathog; 2013; 9(4):e1003310. PubMed ID: 23637601
[TBL] [Abstract][Full Text] [Related]
20. A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Delta32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4.
Naif HM; Cunningham AL; Alali M; Li S; Nasr N; Buhler MM; Schols D; de Clercq E; Stewart G
J Virol; 2002 Apr; 76(7):3114-24. PubMed ID: 11884536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
